Unknown

Dataset Information

0

Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis.


ABSTRACT: Claudin-3 (CLDN3) is a tight junction protein that is overexpressed in 90% of ovarian tumors. Previous in vitro studies have indicated that CLDN3 overexpression promotes the migration, invasion, and survival of ovarian cancer cells. Here, we investigated the efficacy of lipidoid-formulated CLDN3 siRNA in 3 different ovarian cancer models. Intratumoral injection of lipidoid/CLDN3 siRNA into OVCAR-3 xenografts resulted in dramatic silencing of CLDN3, significant reduction in cell proliferation, reduction in tumor growth, and a significant increase in the number of apoptotic cells. Intraperitoneal injection of lipidoid-formulated CLDN3 siRNA resulted in a substantial reduction in tumor burden in MISIIR/TAg transgenic mice and mice bearing tumors derived from mouse ovarian surface epithelial cells. Ascites development was reduced in CLDN3 siRNA-treated mice, suggesting the treatment effectively suppressed metastasis. Toxicity was not observed after multiple i.p. injections. Importantly, treatment of mice with nonimmunostimulatory 2'-OMe modified CLDN3 siRNA was as effective in suppressing tumor growth as unmodifed siRNA. These results suggest that lipidoid-formulated CLDN3 siRNA has potential as a therapeutic for ovarian cancer.

SUBMITTER: Huang YH 

PROVIDER: S-EPMC2651300 | biostudies-literature | 2009 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis.

Huang Yu-Hung YH   Bao Yunhua Y   Peng Weidan W   Goldberg Michael M   Love Kevin K   Bumcrot David A DA   Cole Geoffrey G   Langer Robert R   Anderson Daniel G DG   Sawicki Janet A JA  

Proceedings of the National Academy of Sciences of the United States of America 20090210 9


Claudin-3 (CLDN3) is a tight junction protein that is overexpressed in 90% of ovarian tumors. Previous in vitro studies have indicated that CLDN3 overexpression promotes the migration, invasion, and survival of ovarian cancer cells. Here, we investigated the efficacy of lipidoid-formulated CLDN3 siRNA in 3 different ovarian cancer models. Intratumoral injection of lipidoid/CLDN3 siRNA into OVCAR-3 xenografts resulted in dramatic silencing of CLDN3, significant reduction in cell proliferation, re  ...[more]

Similar Datasets

| S-EPMC8195659 | biostudies-literature
| S-EPMC6198667 | biostudies-literature
| S-EPMC5462394 | biostudies-literature
| S-EPMC3677313 | biostudies-literature
| S-EPMC4191406 | biostudies-literature
| S-EPMC7935315 | biostudies-literature
| S-EPMC4011124 | biostudies-other
| S-EPMC3308985 | biostudies-literature
| S-EPMC7157903 | biostudies-literature
| S-EPMC5378761 | biostudies-other